Conference Proceedings

Tenidap--a new antiarthritic agent.

PM Brooks

Agents and Actions | Published : 1993

Abstract

Tenidap sodium is a novel cytokine inhibitor. Early studies in RA suggest a disease modifying profile as well as providing symptomatic relief. The drug is also effective in OA at a significantly lower dose. The results of clinical trials in RA and OA, which address efficacy and safety, are awaited with interest.